AMYLIN

PARIS (Reuters) - Stock index futures pointed to a higher open on Wall Street on Monday, with futures for the S&P 500 up 0.29 percent, Dow Jones futures up 0.31 percent and Nasdaq 100 futures up 0.3 percent at 5 a.m. EDT.

(Reuters) - La farmacéutica estadounidense Bristol-Myers Squibb acordó la adquisición de Amylin Pharmaceuticals por unos 5.300 millones de dólares (4.220 millones de euros), o 31 dólares por acción, en efectivo.

(Reuters) - Bristol-Myers Squibb Co has agreed to buy biotechnology company Amylin Pharmaceuticals Inc for about $5.3 billion, or $31 per share, in cash, giving Bristol-Myers a stake in the future of diabetes drugs Byetta and Bydureon.

(Reuters) - Bristol-Myers Squibb Co agreed to buy Amylin Pharmaceuticals Inc for about $5.3 billion, or for $31 per share in cash.

By Paritosh Bansal and Soyoung Kim

NEW YORK (Reuters) - Amylin Pharmaceuticals Inc , which spurned a $3.5 billion takeover bid from Bristol-Meyers Squibb Co and is fending off activist investor Carl Icahn, is exploring a sale, sources familiar with the situation said on Sunday.

By Jonathan Stempel

(Reuters) - Shares of Amylin Pharmaceuticals Inc rose as much as 51 percent on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb Co .

By Bill Berkrot

Este comunicado de prensa contiene declaraciones prospectivas sobre Amylin y Lilly. Los resultados reales podrían diferir de los comentados o contenidos en este comunicado debido a una serie de riesgos e incertidumbres, incluyendo el riesgo de que exenatide y los ingresos generados de exenatide podrían verse afectados por l...